223 related articles for article (PubMed ID: 22332960)
1. Rufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox-Gastaut syndrome.
McCormack PL
Pharmacoeconomics; 2012 Mar; 30(3):247-56. PubMed ID: 22332960
[TBL] [Abstract][Full Text] [Related]
2. The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK.
Benedict A; Verdian L; Maclaine G
Pharmacoeconomics; 2010; 28(3):185-99. PubMed ID: 20151724
[TBL] [Abstract][Full Text] [Related]
3. Cost-utility analysis of rufinamide versus topiramate and lamotrigine for the treatment of children with Lennox-Gastaut Syndrome in the United Kingdom.
Verdian L; Yi Y
Seizure; 2010 Jan; 19(1):1-11. PubMed ID: 19942457
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of antiepileptic drugs in the treatment of Lennox-Gastaut syndrome.
Clements KM; Skornicki M; O'Sullivan AK
Epilepsy Behav; 2013 Oct; 29(1):184-9. PubMed ID: 23973644
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and tolerability of rufinamide in children and young adults with Lennox-Gastaut syndrome: a single center study in Korea.
Lee EH; Yum MS; Ko TS
Clin Neurol Neurosurg; 2013 Jul; 115(7):926-9. PubMed ID: 23083943
[TBL] [Abstract][Full Text] [Related]
6. Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan.
Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
Epilepsy Res; 2014 Nov; 108(9):1627-36. PubMed ID: 25219353
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial.
Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
Epilepsy Res; 2016 Mar; 121():1-7. PubMed ID: 26827266
[TBL] [Abstract][Full Text] [Related]
8. Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview.
Wier HA; Cerna A; So TY
Paediatr Drugs; 2011 Apr; 13(2):97-106. PubMed ID: 21351809
[TBL] [Abstract][Full Text] [Related]
9. Rufinamide for the treatment of Lennox-Gastaut syndrome.
Besag FM
Expert Opin Pharmacother; 2011 Apr; 12(5):801-6. PubMed ID: 21348771
[TBL] [Abstract][Full Text] [Related]
10. Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience.
Coppola G; Grosso S; Franzoni E; Veggiotti P; Zamponi N; Parisi P; Spalice A; Habetswallner F; Fels A; Capovilla G; Verrotti A; Mangano S; Balestri A; Curatolo P; Pascotto A
Seizure; 2010 Nov; 19(9):587-91. PubMed ID: 20888268
[TBL] [Abstract][Full Text] [Related]
11. Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study.
Nikanorova M; Brandt C; Auvin S; McMurray R
Epilepsy Behav; 2017 Nov; 76():63-70. PubMed ID: 28927712
[TBL] [Abstract][Full Text] [Related]
12. Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice.
Striano P; McMurray R; Santamarina E; Falip M
Epileptic Disord; 2018 Feb; 20(1):13-29. PubMed ID: 29313492
[TBL] [Abstract][Full Text] [Related]
13. Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome.
Wisniewski CS
Ann Pharmacother; 2010 Apr; 44(4):658-67. PubMed ID: 20233912
[TBL] [Abstract][Full Text] [Related]
14. Rufinamide from clinical trials to clinical practice in the United States and Europe.
Resnick T; Arzimanoglou A; Brown LW; Flamini R; Kerr M; Kluger G; Kothare S; Philip S; Harrison M; Narurkar M
Epileptic Disord; 2011 May; 13 Suppl 1():S27-43. PubMed ID: 21669560
[TBL] [Abstract][Full Text] [Related]
15. Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years.
Conry JA; Ng YT; Kernitsky L; Mitchell WG; Veidemanis R; Drummond R; Isojarvi J; Lee D; Paolicchi JM;
Epilepsia; 2014 Apr; 55(4):558-67. PubMed ID: 24580023
[TBL] [Abstract][Full Text] [Related]
16. Rufinamide as an adjuvant treatment in children with Lennox-Gastaut syndrome.
Kim SH; Eun SH; Kang HC; Kwon EJ; Byeon JH; Lee YM; Lee JS; Eun BL; Kim HD
Seizure; 2012 May; 21(4):288-91. PubMed ID: 22421185
[TBL] [Abstract][Full Text] [Related]
17. Rufinamide efficacy and safety in children aged 1-4 years with Lennox-Gastaut syndrome.
Kim SH; Kang HC; Lee JS; Kim HD
Brain Dev; 2018 Nov; 40(10):897-903. PubMed ID: 30166208
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of rufinamide as adjunctive therapy in patients with Lennox Gastaut syndrome: A systematic review and Meta-analysis.
Sharawat IK; Panda PK; Panda P; Dawman L
Seizure; 2021 Oct; 91():296-307. PubMed ID: 34273668
[TBL] [Abstract][Full Text] [Related]
19. Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.
Cramer JA; Sapin C; François C
Acta Neurol Scand; 2013 Aug; 128(2):91-9. PubMed ID: 23410109
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Lennox-Gastaut syndrome.
Hancock EC; Cross JH
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD003277. PubMed ID: 23450537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
